Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velaglucerase alfa in Type 1 Gaucher Disease
NCT00430625Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2007
- Primary completion
- Apr 2009
- Modality
- Replacement Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of velaglucerase alfa in Gaucher disease type 1 (GD1), sponsored by Takeda. Started Feb 2007; status: completed.
02
Drugs
velaglucerase alfa
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00430625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430625.